Metalloenzyme active sites: nitrogenase, cytochrome P450, and zinc proteases
Anchor (Master): Lippard & Berg — Principles of Bioinorganic Chemistry (1994)
Metalloenzyme active sites: nitrogenase, cytochrome P450, and zinc proteases
Intuition Beginner
Many enzymes need metal atoms to do their chemistry. The metal sits in a pocket of the protein called the active site, where it binds substrates and transforms them. Three classic examples illustrate different strategies.
Nitrogenase holds an iron–molybdenum cluster that cracks the strong triple bond in N₂, converting atmospheric nitrogen into ammonia the cell can use. This is biological nitrogen fixation, and it runs at ambient temperature and pressure — conditions industrial Haber–Bosch cannot match.
Cytochrome P450 enzymes contain a heme-bound iron centre. They use molecular oxygen to insert a single oxygen atom into C–H bonds of organic molecules, turning inert substrates into more polar products. Your liver relies on P450 enzymes to metabolise drugs and toxins.
Zinc proteases deploy a Zn²⁺ ion as a Lewis acid. The zinc polarises a water molecule, making it a better nucleophile that attacks peptide bonds or CO₂. Carbonic anhydrase, one of the fastest enzymes known, uses this strategy to interconvert CO₂ and bicarbonate.
Visual Beginner
The diagram above shows schematic active-site geometries for each enzyme class: the FeMo-cofactor of nitrogenase, the heme iron of cytochrome P450, and the tetrahedral zinc centre of a protease.
Worked example Beginner
Carbonic anhydrase catalyses CO₂ + H₂O ⇌ HCO₃⁻ + H⁺. The zinc ion sits in a tetrahedral site coordinated by three histidine residues and one water molecule. Zinc withdraws electron density from the bound water, lowering its pKₐ from ~15 to ~7. At physiological pH the resulting hydroxide is a potent nucleophile. It attacks the electrophilic carbon of CO₂ to form bicarbonate, which dissociates and is replaced by a new water molecule, resetting the cycle.
Check your understanding Beginner
Formal definition Intermediate+
The active site of a metalloenzyme is the coordination environment of one or more metal ions within the protein scaffold where substrate binding and chemical transformation occur. The geometry, ligand set, and oxidation-state accessibility of the metal centre determine catalytic function.
Nitrogenase FeMo-cofactor. The MoFe protein of molybdenum nitrogenase contains the Fe₇MoS₉C(homocitrate) cofactor (FeMo-co). The cluster is a [7Fe:9S
Cytochrome P450 catalytic cycle. The resting state is Fe(III) low-spin in a porphyrin ligand field with a cysteinate axial ligand. Substrate binding displaces a coordinated water, shifting to high-spin Fe(III) and raising the reduction potential. One-electron reduction yields Fe(II), which binds O₂. A second electron and protonation generate a ferric-hydroperoxo intermediate. O–O bond heterolysis releases water and produces Compound I — a formally Fe(IV)=O porphyrin radical cation (oxoferryl species). Compound I is the oxidant that inserts oxygen into the substrate C–H bond via hydrogen-atom abstraction and radical rebound.
Zinc protease mechanism. In carbonic anhydrase II, Zn²⁺ is tetrahedrally coordinated by three His residues and one H₂O/OH⁻. The zinc ion acts as a Lewis acid, polarising the bound water and stabilising the developing negative charge in the transition state. In carboxypeptidase A, the zinc activates a water molecule for nucleophilic attack on the scissile peptide bond, assisted by general-base catalysis from Glu-270. The Lewis acidity of Zn²⁺ (no accessible redox chemistry under biological conditions) makes it ideal for hydrolytic rather than redox catalysis.
Key parameters
| Enzyme | Metal | Oxidation states accessed | Primary function |
|---|---|---|---|
| Nitrogenase (Mo) | Fe, Mo | Fe(II/III), Mo(III/IV) | Multi-electron reduction of N₂ |
| Cytochrome P450 | Fe | Fe(II/III/IV) | O-atom transfer via oxoferryl |
| Carbonic anhydrase | Zn | Zn(II) only | Lewis acid activation of H₂O |
| Carboxypeptidase A | Zn | Zn(II) only | Peptide bond hydrolysis |
Key mechanism Intermediate+
The three metalloenzymes studied here illustrate distinct catalytic strategies. Nitrogenase achieves the remarkable six-electron, six-proton reduction of N to 2 NH at the FeMo-cofactor, using ATP hydrolysis to drive electron transfer from the Fe protein to the MoFe protein. Cytochrome P450 activates molecular oxygen through sequential one-electron reductions to generate the oxoferryl Compound I (Fe(IV)=O porphyrin radical), which abstracts a hydrogen atom from the substrate. Zinc proteases employ a purely Lewis acid strategy: Zn polarises a bound water molecule, lowering its pK to generate a zinc-bound hydroxide that attacks the carbonyl carbon of the substrate.
Exercises Intermediate+
Biosynthesis of the FeMo-cofactor Master
The FeMo-cofactor is not assembled directly in the MoFe protein. Biosynthesis proceeds on a scaffold protein, NifEN, through a sequence of radical SAM-dependent steps mediated by NifB. NifB synthesises a [4Fe–4S] precursor that is fused and rearranged into the [8Fe–7S] core, with insertion of the interstitial carbide derived from SAM. The finished cofactor is transferred to the MoFe protein (NifDK) with the assistance of NifX, NifY, and other accessory factors. Molybdenum and homocitrate are incorporated late in the pathway, with NifQ and NifV supplying these components respectively.
Alternative nitrogenases
Three classes of nitrogenase exist: Mo-dependent (Nif), vanadium-dependent (Vnf), and iron-only (Anf). The V-nitrogenase replaces Mo with V in a homologous cofactor; the Fe-only nitrogenase dispenses with the heterometal entirely. All three share the Fe protein electron donor but differ in their substrate profiles and turnover rates. V-nitrogenase reduces CO to hydrocarbons under certain conditions, a reactivity not observed for the Mo system. The evolutionary rationale for maintaining multiple nitrogenases may relate to metal availability in different ecological niches — Mo is scarce in some soils and ocean environments.
Cytochrome P450 substrate specificity and drug metabolism
The human genome encodes 57 cytochrome P450 enzymes (CYPs). Substrate specificity is governed not only by the heme environment but by the access channels, substrate recognition sites (SRS), and conformational flexibility of the protein scaffold. CYP3A4, the most abundant hepatic P450, metabolises roughly half of all clinically used drugs. Its large active-site cavity accommodates diverse substrates, leading to clinically significant drug–drug interactions. CYP2D6 is polymorphic in human populations; poor metaboliser phenotypes alter drug efficacy and toxicity profiles. Understanding P450 active-site structure is therefore directly relevant to pharmacokinetics and personalised medicine.
Metallo-beta-lactamases
Metallo-beta-lactamases (MBLs) are zinc-dependent enzymes that hydrolyse beta-lactam antibiotics, conferring bacterial resistance. Class B1 MBLs (e.g., NDM-1, VIM-2) use a dinuclear zinc centre: one Zn²⁺ activates a hydrolytic water, while the second stabilises the anionic intermediate formed during ring opening. Unlike serine beta-lactamases, MBLs are not inhibited by clavulanic acid, making them a serious clinical concern. Inhibitor design requires mimicking the tetrahedral transition state while coordinating both zinc ions — an active area of medicinal chemistry research.
Biomimetic model complexes
Synthetic chemists have built small-molecule models of each active site to test mechanistic hypotheses and develop new catalysts. Key milestones include Cummins' three-coordinate molybdenum complex that cleaves N₂ at a single metal centre, Karlin's copper–dioxygen adducts modelling P450 reactivity with a different metal, and Parkin's zinc hydroxide complexes reproducing carbonic anhydrase reactivity. Biomimetic approaches reveal that the protein environment is often doing more than the metal alone — second-sphere hydrogen bonding, hydrophobic effects, and conformational gating all contribute to rate enhancements that small-molecule models have not fully replicated.
Connections Master
- Unit 16.06.02 (Coordination chemistry in biology) provides the ligand-field and hard-soft framework needed to rationalise metal selection in each enzyme.
- Unit 16.04 (Redox chemistry) underpins the multi-electron redox cycles of nitrogenase and P450, including the concept of redox potential modulation by ligand field.
- Unit 16.05 (Solid-state and materials) connects to heterogeneous catalysis: the Haber–Bosch process achieves the same transformation as nitrogenase but requires extreme conditions, highlighting the sophistication of the biological catalyst.
- Unit 16.06.04 (Metal transport and homeostasis) follows from the observation that cells must acquire, traffic, and regulate Mo, Fe, and Zn to assemble and maintain these active sites.
- Pharmacology and drug design. P450-mediated drug metabolism directly determines dosing, drug–drug interactions, and toxicity. MBL-mediated antibiotic resistance is a pressing clinical problem.
Historical notes Master
The identification of metals in enzymes accelerated in the 1950s and 1960s. Carbonic anhydrase was recognised as a zinc enzyme by Keilin and Mann (1940), but the mechanistic role of zinc was only clarified with X-ray structures by Lipscomb's group in the 1970s. Cytochrome P450 was discovered by Omura and Sato in 1964; the "P450" designation refers to its absorbance peak at 450 nm when the reduced enzyme binds CO. The FeMo-cofactor was isolated by Shah and Brill in 1977, but the interstitial carbide was not identified until 2011 — by X-ray emission spectroscopy and anomalous dispersion — over three decades after the cofactor's discovery. The crystal structure of the MoFe protein at atomic resolution by Rees and coworkers (1992) revealed the full cluster geometry. Alternative nitrogenases were discovered in the 1980s by Bishop and colleagues. Metallo-beta-lactamases emerged as a clinical threat in the 1990s, with NDM-1 first reported in 2009.
Bibliography Master
- Miessler, G. L., Fischer, P. J. & Tarr, D. A. Inorganic Chemistry, 5th ed. (Pearson, 2014). Ch. 11.
- Shriver, D. F. & Atkins, P. W. Inorganic Chemistry, 5th ed. (Oxford, 2010). Ch. 11.
- Lippard, S. J. & Berg, J. M. Principles of Bioinorganic Chemistry (University Science Books, 1994). Ch. 6–7.
- Howard, J. B. & Rees, D. C. "Structural Basis of Biological Nitrogen Fixation." Chem. Rev. 1996, 96, 2965–2982.
- Ortiz de Montellano, P. R. (ed.) Cytochrome P450: Structure, Mechanism, and Biochemistry, 4th ed. (Springer, 2015).
- Lipscomb, W. N. & Strater, N. "Recent Advances in Zinc Enzymology." Chem. Rev. 1996, 96, 2375–2434.
- Beinert, H., Holm, R. H. & Munck, E. "Iron-Sulfur Clusters: Nature's Modular, Multipurpose Structures." Science 1997, 277, 653–659.